Bile Acid Receptor (NR1H4) Antibody
351€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Bile Acid Receptor (NR1H4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx376011
tested applications
ELISA, WB
Description
Bile Acid Receptor (NR1H4) Antibody is a Rabbit Polyclonal antibody against Bile Acid Receptor (NR1H4).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Bile Acid Receptor (NR1H4) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by affinity chromatography using epitope-specific immunogen. |
| Size 1 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Buffer | PBS, pH 7.4, containing 0.02% sodium azide and 50% glycerol. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q96RI1 |
| Gene ID | 9971 |
| Alias | BAR,FXR,HRR1,HRR-1,PFIC5,RIP14,Bile acid receptor,Farnesoid X-activated receptor,Nuclear receptor subfamily 1 group H member 4 |
| Background | Antibody anti-NR1H4 |
| Status | RUO |
| Note | Concentration: 1 mg/ml - |
Descripción
Nuclear receptor subfamily 1 group H member 4 (NR1H4), also known as FXR (farnesoid X receptor), is a nuclear receptor that plays a crucial role in regulating bile acid metabolism, liver function, and glucose homeostasis NR1H4 is expressed primarily in the liver, intestine, and kidneys, where it regulates the synthesis, transport, and catabolism of bile acids, which are essential for digestion and the absorption of fats FXR also influences lipid and glucose metabolism, helping maintain energy balance and insulin sensitivity in the liver and other metabolic tissues It plays a key role in protecting the liver from bile acid toxicity by regulating the expression of genes involved in bile acid homeostasis Dysregulation of FXR signaling has been associated with liver diseases such as non-alcoholic fatty liver disease (NAFLD), cirrhosis, and cholestasis, as well as metabolic diseases like obesity and diabetes FXR has emerged as a therapeutic target for managing liver diseases, metabolic syndrome, and conditions related to bile acid imbalances, making it an important receptor for drug development in these areas
Related Products
Human NR1H4 (Bile acid receptor) ELISA Kit
Ver Producto
Mouse NR1H4 (Bile acid receptor) ELISA kit
Ver Producto
Bile Acid Receptor (NR1H4) Antibody
NR1H4 Antibody is a Rabbit Polyclonal Antibody against NR1H4.
Ver Producto